Elsevier

Appetite

Volume 68, 1 September 2013, Pages 56-62
Appetite

Research report
Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey

https://doi.org/10.1016/j.appet.2013.04.016Get rights and content

Highlights

  • Non-adherence to the gluten-free diet involves intentional and inadvertent lapses.

  • Intentional lapses are common but less frequent than inadvertent lapses.

  • Contributing factors affect both types of non-adherence in different ways.

  • Intention, perceived tolerance and self-efficacy predicted intentional lapses.

  • Psychosocial factors do not explain inadvertent lapses as well as intentional ones.

Abstract

Adherence to a gluten-free diet is the mainstay of treatment for coeliac disease. Non-adherence is common as the diet is restrictive and can be difficult to follow. This study aimed to determine the rates of intentional and inadvertent non-adherence in adult coeliac disease and to examine the factors associated with both. A self-completion questionnaire was mailed to adult coeliac patients identified from the computer records of 31 family practices within the North East of England. We received 287 responses after one reminder. Intentional gluten consumption was reported by 115 (40%) of respondents. 155 (54%) had made at least one known mistaken lapse over the same period and 82 (29%) reported neither intentional nor mistaken gluten consumption. Using logistic regression analysis, low self-efficacy, perceptions of tolerance to gluten and intention were found to be independently predictive of intentional gluten consumption. A statistical model predicted 71.8% of cases reporting intentional lapses. Intentional non-adherence to the GFD was found to be common but not as frequent as inadvertent lapses. Distinguishing the factors influencing both intentional and inadvertent non-adherence is useful in understanding dietary self-management in coeliac disease.

Introduction

Coeliac disease (CD) is a chronic inflammatory intestinal disorder characterised by a heightened immunological response to ingested gluten in genetically susceptible individuals. Originally a disease of childhood, CD is now more frequently first diagnosed in adults and has a prevalence of around 1% in Europe and the US (Bingley et al., 2004, Dube et al., 2005, Lohi et al., 2007, West et al., 2003). This change in presentation is partly explained by the increasing use of serological tests for active case-finding and for targeted screening in high risk groups (Collin, 2005, Hin et al., 1999, Jones, 2007, Korponay-Szabo et al., 2005). Advances in diagnostic testing, together with improved recognition of CD (National Institute for Health, 2009), have also resulted in an increased number of individuals diagnosed with atypical, minimal or no symptoms (Mulder & Cellier, 2005). The mainstay of treatment for CD is strict life-long adherence to a gluten-free diet (GFD). For most patients, this results in full clinical and histological remission (Holmes & Catassi, 2000) and is associated with improvements in symptoms and quality of life (Midhagen & Hallert, 2003), a decrease in long term health risks and health gains for problems associated with CD such as infertility, fatigue (Siniscalchi et al., 2005), and depression (Hallert and Sedvall, 1983, Hallert et al., 2002, Whitaker et al., 2009). The GFD is restrictive and can be difficult for some patients to follow, however, and the most common cause of persistent symptoms is gluten consumption (Dewar et al., 2012, Hopper et al., 2007). This is compounded by confusing food labelling and the expense and limited availability of GF foods despite their availability on prescription in the UK and other European countries and increasing availability of GF foods in supermarkets. Adherence to the GFD is reported to range between 36% and 96% and is associated with a variety of demographic, psychosocial and clinical factors (Ford et al., 2012, Hall et al., 2009, Sainsbury and Mullan, 2011). Adherence is not usually conceptualised in behavioural terms, despite the acknowledgement of both intentional and inadvertent gluten consumption within the literature (Black and Orfila, 2011, Casellas et al., 2009, Dewar et al., 2012, Vahedi et al., 2003). No study has specifically examined the factors associated with each type of non-adherence in coeliac disease. Although the primary concern in terms of clinical outcomes is actual gluten consumption, greater understanding of these very different behaviours is important in understanding dietary self-management and may inform potential interventions. This study investigates the factors associated with both intentional and inadvertent gluten consumption in adults with CD.

Section snippets

Methods

A total of 31 family group practices in North East England, covering both rural and urban areas, participated in the study. Using Read code searches of their computerised clinical records, they identified all adult coeliac disease patients, to whom they then posted a self-completion questionnaire (n = 566). A reminder was sent 10–14 days after the initial mailing. The response rate was 53.9% (n = 305). Ten participants reported not having been diagnosed with coeliac disease, seven responses were

Results

One hundred and fifteen (40.1%) respondents reported having intentionally consumed gluten consumption over the last 6 months, of whom 102 (88.7%) also reported inadvertent gluten consumption. Overall 155 (54.0%) had mistakenly consumed gluten at least once over the same period. 71 (24.7%) had not intentionally consumed gluten, and had made only one or two mistakes. Eighty two (28.6%) reported not having consumed gluten either intentionally or inadvertently. See Fig. 1.

Some respondents (n = 19, 7%)

Discussion

This is the first study to characterise intentional and inadvertent non-adherence to a gluten-free diet in patients with coeliac disease. Our findings add to those from other studies looking at the association between concepts from existing theories of health behaviour (Ford et al., 2012, Leffler et al., 2008, Sainsbury and Mullan, 2011), by demonstrating the importance of this distinction in understanding adherence to the GFD. Both types of non-adherence are common with only 28% of respondents

Conclusion

Distinguishing between intentional and unintentional gluten consumption is important in understanding dietary self-management in CD. Mistaken gluten consumption is more frequent than intentional consumption and these two types of non-adherence are explained by different factors. Constructs from social cognitive models of health behaviour usefully predict intentional gluten consumption but are less useful for inadvertent consumption. Our findings suggest that interventions based on theories of

References (51)

  • I. Ajzen

    The theory of planned behavior

    Organizational Behavior and Human Decision Processes

    (1991)
  • Ajzen, I. (2006). Constructing a theory of planned behaviour questionnaire. Conceptual and methodological...
  • A.K. Akobeng et al.

    Systematic review. Tolerable amount of gluten for people with coeliac disease

    Alimentary Pharmacology and Therapeutics

    (2008)
  • A. Bandura

    Social foundations of thought and action. A social cognitive theory

    (1986)
  • A. Bandura

    Health promotion from the perspective of social cognitive theory

  • S.M. Barratt et al.

    Quality of life in coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved

    Journal of Gastrointestinal and Liver Diseases

    (2011)
  • J.R. Bebb et al.

    Long-term follow-up of coeliac disease. What do coeliac patients want?

    Alimentary Pharmacology and Therapeutics

    (2006)
  • F. Biagi et al.

    A score that verifies adherence to a gluten-free diet. A cross-sectional, multicentre validation in real clinical life

    British Journal of Nutrition

    (2012)
  • P.J. Bingley et al.

    Undiagnosed coeliac disease at age seven. Population based prospective birth cohort study

    British Medical Journal

    (2004)
  • J.L. Black et al.

    Impact of coeliac disease on dietary habits and quality of life

    Journal of Human Nutrition and Dietetics

    (2011)
  • J.R. Butterworth et al.

    Factors relating to compliance with a gluten-free diet in patients with coeliac disease. Comparison of white Caucasian and South Asian patients

    Clinical Nutrition

    (2004)
  • F. Casellas et al.

    Current epidemiology and accessibility to diet compliance in adult coeliac disease

    Revista Espanola De Enfermedades Digestivas

    (2009)
  • C. Catassi et al.

    A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with coeliac disease

    American Journal of Clinical Nutrition

    (2007)
  • P. Collin

    Should adults be screened for coeliac disease? What are the benefits and harms of screening?

    Gastroenterology

    (2005)
  • P. Collin et al.

    It is the compliance, not milligrams of gluten, that is essential in the treatment of coeliac disease

    Nutrition Review

    (2004)
  • P. Collin et al.

    Safe gluten threshold for patients with coeliac disease. Some patients are more tolerant than others

    American Journal of Clinical Nutrition

    (2007)
  • I. Comino et al.

    Diversity in oat potential immunogenicity. Basis for the selection of oat varieties with no toxicity in coeliac disease

    Gut

    (2011)
  • D.H. Dewar et al.

    Celiac disease. Management of persistent symptoms in patients on a gluten-free diet

    World Journal of Gastroenterology

    (2012)
  • C. Dube et al.

    The prevalence of coeliac disease in average-risk and at-risk Western European populations. A systematic review

    Gastroenterology

    (2005)
  • J.B. Edwards-George et al.

    Psychological correlates of gluten-free diet adherence in adults with coeliac disease

    Journal of Clinical Gastroenterology

    (2009)
  • S. Ford et al.

    Psychosocial aspects of coeliac disease. A cross-sectional survey of a UK population

    British Journal of Health Psychology

    (2012)
  • P.H. Green et al.

    Risk of malignancy in patients with coeliac disease

    American Journal of Medicine

    (2003)
  • M.L. Haines et al.

    Systematic review. The evidence base for long-term management of coeliac disease

    Alimentary Pharmacology and Therapeutics

    (2008)
  • Hall, N. (2010). Adherence to the gluten-free diet in adult coeliac disease. PhD thesis. University of...
  • N. Hall et al.

    Systematic review. Adherence to a gluten-free diet in adult patients with coeliac disease

    Alimentary Pharmacology and Therapeutics

    (2009)
  • Cited by (83)

    • Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials

      2022, Clinics and Research in Hepatology and Gastroenterology
      Citation Excerpt :

      Additional challenges include the financial expensiveness and unavailability of gluten-free products when compared with their gluten-containing equivalents [6]. These challenges are further compounded by several reports documenting the intentional and unintentional gluten ingestion by CD patients [7,8]. Unfortunately, a mere GFD is not adequate to halt the disease pathogenesis or dramatically lessen symptoms in a large proportion of CD patients [9].

    • Oral enzyme strategy in celiac disease

      2021, Biotechnological Strategies for the Treatment of Gluten Intolerance
    • Treatment of gluten-related disorders

      2021, Gluten-Related Disorders: Diagnostic Approaches, Treatment Pathways, and Future Perspectives
    View all citing articles on Scopus

    Acknowledgements: This study was supported financially by a PhD support grant from the former Northern Primary Care Research Network and the University of Sunderland. We acknowledge the support of the GP practices and Primary Care Research Network (Northern and Yorkshire) who assisted with participant recruitment, all the members of the study steering group and, in particular, our participants.

    View full text